Podcast: AI in oncology – the trials, tribulations and opportunities

Medidata's CEO talks through AI's potential in oncology clinical trials, while advising on how the technology can be effectively implemented. As AI becomes increasingly embedded into clinical trials operations, sponsors must find a way to effectively implement the technology to get the most out of it. .Medidata’s CEO, Anthony Costello, talks about how AI can be effectively incorporated into oncology clinical trials. Credit: Sergey Mironov via Getty Images In recent years, artificial intelligence (AI) has become one of the largest talking points within the pharma space – a trend we also see strongly within the clinical trials sector. With its…

Source: Clinical Trials Arena